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The N-end rule relates the in vivo half-life of a protein to the
identity of its N-terminal residue. A subset of degradation signals
recognized by the N-end rule pathway comprises the signals, called
N-degrons, whose determinants include destabilizing N-terminal
residues. Our previous work identified a family of at least four
mammalian E3 ubiquitin ligases, including UBR1 and UBR2, that
share the UBR box and recognize N-degrons. These E3 enzymes
mediate the multifunctional N-end rule pathway, but their indi-
vidual roles are just beginning to emerge. Mutations of UBR1 in
humans are the cause of Johanson–Blizzard syndrome. UBR1 and
UBR2 are 46% identical and appear to be indistinguishable in their
recognition of N-degrons.UBR1/mice are viable but have defects
that include pancreatic insufficiency, similarly to UBR1/ human
patients with Johanson–Blizzard syndrome. UBR2/ mice are
inviable in some strain backgrounds and are defective in male
meiosis. To examine functional relationships between UBR1 and
UBR2, we constructed mouse strains lacking both of these E3s. We
report here that UBR1/UBR2/ embryos die at midgestation,
with defects in neurogenesis and cardiovascular development.
These defects included reduced proliferation as well as precocious
migration and differentiation of neural progenitor cells. The ex-
pression of regulators such as D-type cyclins and Notch1 was also
altered in UBR1/UBR2/ embryos. We conclude that the func-
tions of UBR1 and UBR2 are significantly divergent, in part because
of differences in their expression patterns and possibly also be-
cause of differences in their recognition of protein substrates that
contain degradation signals other than N-degrons.
ubiquitylation  proteolysis  N-recognin  UBR box  arginylation
A protein substrate of the ubiquitin (Ub)-proteasome system,which controls the levels of many intracellular proteins, is
conjugated to Ub through the action of E1, E2, and E3 enzymes
(1–5). The substrate’s degradation signal (degron) is recognized by
E3. A ubiquitylated protein bears a covalently linked polyUb chain
and is degraded by the 26S proteasome (3, 5). The term ‘‘Ub ligase’’
denotes either an E2–E3 holoenzyme or its E3 component. An
essential determinant of one class of degrons, called N-degrons, is
a substrate’s destabilizing N-terminal residue. The set of destabi-
lizing residues in a given cell type yields a rule, called theN-end rule,
that relates the in vivo half-life of a protein to the identity of its
N-terminal residue (1, 6). In eukaryotes, the N-degron consists of
three determinants: a destabilizing N-terminal residue of a protein
substrate, its internal Lys residue(s) (the site of formation of a
polyUb chain), and a conformationally flexible region (or regions)
in the vicinity of these determinants that is required for the
substrate’s ubiquitylation andor degradation (6–9).
The N-end rule has a hierarchic structure (Fig. 1A). In eu-
karyotes, N-terminalAsn andGln are tertiary destabilizing residues
in that they function through their enzymatic deamidation (10, 11)
to yield the secondary destabilizing N-terminal residues Asp and
Glu (Fig. 1A). The activity of Asp and Glu requires their conju-
gation, by ATE1-encoded isoforms of Arg-tRNA-protein trans-
ferase (R-transferase), to Arg, one of the primary destabilizing
residues (12–15). The latter are recognized by E3 Ub ligases of the
N-end rule pathway (Fig. 1A). In mammals and other eukaryotes
that produce nitric oxide (NO), the set of arginylated residues
contains not only Asp and Glu but also N-terminal Cys, which is
arginylated after its oxidation. The latter requires both NO and
oxygen (O2) (Fig. 1A) (14, 15). The functions of the N-end rule
pathway include the control of peptide import (through the con-
ditional degradation of import’s repressor) (16, 17), the fidelity of
chromosome segregation (through the degradation of a condition-
ally produced cohesin’s fragment) (18), the regulation of apoptosis
(through the degradation of a caspase-processed inhibitor of apo-
ptosis) (19, 20), the regulation of meiosis (21), leaf senescence in
plants (22), and cardiovascular development in mammals (13). The
last of these processes involves the N-end rule pathway in part
through the NOO2-dependent, arginylation-mediated degrada-
tion of regulator of G protein signaling (RGS) proteins RGS4,
RGS5, and RGS16, a set of GTPase-activating proteins that bear
N-terminal Cys, inhibit the signaling by specific G proteins, and are
themselves down-regulated by the N-end rule pathway, at rates
controlled by NO and O2 (14, 15).
The E3s that recognize N-degrons are called N-recognins (4, 6,
17). In the yeast Saccharomyces cerevisiae, the N-end rule pathway
is mediated by a single N-recognin, UBR1, which contains at least
three substrate-binding sites (17). The type-1 and type-2 sites bind,
respectively, to basic (Arg, Lys, and His) and bulky hydrophobic
(Phe, Leu, Trp, Tyr, and Ile) N-terminal residues of either protein
substrates or short peptides (4, 6, 17). The third binding site
recognizes internal (non-N-terminal) degrons and is inaccessible to
substrates in the autoinhibited UBR1 conformation but can be
allosterically activated by the binding of peptides with destabilizing
N-terminal residues to the type-1 and type-2 sites of UBR1. The
third substrate-binding site of yeast UBR1 targets CUP9, a tran-
scriptional repressor that down-regulates, in particular, the expres-
sion of PTR2, a peptide transporter, and thereby mediates the
control of peptide import by the N-end rule pathway (16, 17). Our
previous work (4, 21, 23, 24) identified mammalian E3s termed
UBR1 andUBR2, two sequelogs (25) of S. cerevisiaeUBR1.Mouse
UBR1 and UBR2 are 46% identical and are apparently indistin-
guishable in their recognition of N-degrons (21). More recent work
expanded the family of (operationally defined) N-recognins to at
least four proteins: UBR1, UBR2, UBR4, and UBR5 (4). One
common feature of these E3s and of several other E3s, termed
UBR3, UBR6, and UBR7, is the presence of an 70-residue
CysHis-rich domain termed the UBR box (4).
We constructed mouse strains lacking some components of the
N-end rule pathway (Fig. 1A) (4, 11, 13, 21, 24). NTAN1/ mice,
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which lacked deamidation of N-terminal Asn, were viable, fertile,
and anatomically normal but exhibited abnormalities in learning,
memory, and behavior (11). ATE1/ mice, which lacked N-
terminal arginylation, died as embryos, with cardiovascular defects
that included ventricular hypoplasia, ventricular septal defects, and
delayed angiogenesis (13). UBR1/mice, which lacked the found-
ing member of the set of N-end rule’s E3s, were viable and fertile
but were leaner than wild-type littermates, exhibited a perturbed
regulation of fatty acid synthase, had amild hypoglycemia, andwere
behaviorally abnormal (24). Mutations in human UBR1 were
recently shown to be the cause of Johanson–Blizzard syndrome,
which comprises mental retardation, physical malformations, and
severe pancreatitis (26). Further analysis of UBR1/ mice has
revealed that they also exhibit exocrine pancreatic insufficiency, a
less severe version of the defect in human Johanson–Blizzard
syndrome (UBR1/) patients (26). UBR2/ mice, which lacked
the second characterized N-recognin, exhibited both gender- and
strain-specific lethality. For example, in the C57129 hybrid back-
ground, UBR2/ males were viable but infertile, owing to defects
in the homologous chromosome pairing during meiotic prophase I,
whereas most UBR2/ females died as embryos (21).
In the present work, we extended genetic analysis of the N-end
rule pathway to a double-mutant setting by constructing mouse
strains that lacked both UBR1 and UBR2. UBR1/UBR2/
embryos died at midgestation, with defects in both neurogenesis
and cardiovascular development. We conclude that the functions
of UBR1 and UBR2 are significantly divergent, in part because of
differences in their expression patterns and possibly also because
of differences in their recognition of substrates that contain deg-
radation signals other than N-degrons.
Results and Discussion
Loss of both UBR1 and UBR2 Results in Embryonic Lethality. We
produced mice of the UBR1/UBR2/ genotype by using com-
pound heterozygous crosses. The UBR1/ and UBR2/ mouse
strains (21, 24) were intercrossed, yielding (apparently normal)
UBR1/UBR2/ mice in the C57BL6129 background. The
progeny of subsequent crosses betweenUBR1/UBR2/mice did
not contain surviving UBR1/UBR2/ pups, suggesting that the
absence of both UBR1 and UBR2 causes embryonic or neonatal
lethality. To address these issues, we examined 1,000 embryos at
various stages of development, mainly at embryonic days (ED)
7.5–13.5, that were produced in timed intercrosses between
UBR1/UBR2/ andor UBR1/ UBR2/ mice. ED9.5
UBR1/UBR2/ embryos were recovered alive and seemed
indistinguishable from their control littermates, both anatomically
and sizewise (Fig. 1 C andD). ED10.5 UBR1/UBR2/ embryos
were also recovered alive and were apparently normal in regard to
the neural tube closure, axial rotation, the appearance of branchial
arches, and the anterior limb bud development. However, the
ED10.5 double-mutant embryos were consistently smaller than
littermate controls (Fig. 1 F and G). ED11.5 UBR1/UBR2/
mutants were found to be either dead or still alive but strongly
growth-retarded, their growth having ceased at ED10.5 (Fig. 1 I
and J). No live UBR1/UBR2/ embryos were recovered at
ED12.5.
Impaired Neurogenesis in Embryos Lacking UBR1 and UBR2. The
appearance of neural tubes in ED10.5 UBR1/UBR2/ embryos
was apparently normal, but by ED11.5, the tubes became strongly
kinked (Fig. 2 G and H, arrowheads). The neuroepithelium of
ED10.5 UBR1/UBR2/ embryos was found to be abnormally
thin; this defect was more severe in the forebrain than in the spinal
cord (Fig. 2 A–D). Neuroepithelial structures inUBR1/UBR2/
embryos did not increase in thickness after ED10.5, in contrast to
control embryos (Fig. 2E andF and data not shown), suggesting the
cessation of cell proliferation at ED10.25–10.5. Nevertheless,
these UBR1/UBR2/ cells contained neurofilaments, a marker
ofmature neurons, at levels comparable to those in control embryos
(Fig. 2 A and B), suggesting that the development of, for example,
the spinal cord was grossly normal in UBR1/UBR2/ embryos
until ED10.25. By ED11.5, the morphology of the forebrain in
UBR1/UBR2/ embryos became grossly distorted, with serpen-
tine, thin, often disjointed neuroepithelial layers of varying thick-
ness (Fig. 2 E and F). These defects in ED11.5 UBR1/UBR2/
embryos might result from the continuing operation of develop-
mental programs, such as cell differentiation andmigration, despite
the absence of wild-type amounts of neuronal precursor cells.
Mammalian neurogenesis begins with a stem cell-like self-
renewal of neural progenitor cells (27, 28). In the course of
neurogenesis, neural precursor cells undergo several rounds of
division at the ventricular zone (VZ) (see Fig. 3E). These cells then
migrate from the VZ to the differentiation zone (mantle), which is
composed of postmitotic differentiating neurons and glia, and
differentiate there, resulting in radially arranged layers of neurons
(27, 28). We injected BrdU into pregnant mice and compared the
amounts of BrdU-positive cells in transverse sections of ED10.5
UBR1/UBR2/ embryos and littermate controls. In control
embryos, BrdU was incorporated, as expected, into cells of the VZ
(Fig. 3E). The levels of S-phase cells (BrdU-positive, stained red)
were consistently lower in the neural tissues of ED10.5
UBR1/UBR2/ embryos, throughout the anteroposterior axis,
Fig. 1. Gross morphology of UBR1/UBR2/ mouse embryos. (A) The
mammalian N-end rule pathway (4, 21). N-terminal residues are indicated by
single-letter abbreviations for amino acids. The ovals denote the rest of a
protein substrate. C*, oxidized Cys residue (14, 15). (B–J) The appearance of
control and UBR1/UBR2/ embryos at ED9.5 (B–D), ED10.5 (E–G), and
ED11.5 (H–J). Markings are as follows: arrow, heart; asterisk, swollen pericar-
dial sac; arrowhead, a hemorrhage. (Scale bar: 1 mm.)














than in control embryos (Fig. 3 B, D, F, and H; compare with Fig.
3 A, C, E, andG). Thus, both morphological data (Fig. 2 A–F) and
the levels of S-phase cells (Fig. 3 A–H) indicated that the prolifer-
ation of neural precursors was impaired in the absence of UBR1
and UBR2. The amounts of neural cells expressing Ki67, a marker
for cells active in the cell cycle, were comparable in control and
UBR1/UBR2/ embryos (Fig. 3M), suggesting that the impaired
proliferation was not caused by cells entering a mitotically quies-
cent, G0-like state.
We also stained cells in the neural tube with antibody to
phosphohistone H3 (pH3), a marker for cells in mitosis. In control
embryos, pH3-positive (stained green) mitotic cells were observed
at the apical surface of the VZ, a layer closest to the lumen (Fig. 3
A, C, E, and G). However, much higher numbers of pH3-positive
mitotic neural precursors were present in similar regions of the
forebrain in ED10.5 UBR1/UBR2/ embryos (Fig. 3B). More-
over, the distribution of mutant mitotic cells was overtly disorga-
nized in that theywere also found throughout the layer lateral to the
VZ (Fig. 3F; see below). In contrast, the pH3 index was similar for
control andUBR1/UBR2/ embryos in the hindbrain, and in the
spinal cord, the pattern was even partially reversed (Fig. 3 C–H),
suggesting that the perturbed proliferation of UBR1/UBR2/
cells was a function of cells’ position along the anteroposterior axis.
Furthermore, mitotic cells in control embryos were mainly at
prophase or prometaphase (Fig. 3I a and b), whereas many pH3-
positive mitotic cells inUBR1/UBR2/ embryos appeared to be
between the interphase and prophase (Fig. 3I c and d), suggesting
an arrest, possibly a transient one, at the G2–M transition. We also
asked, by using theTUNELassay, whether apoptotic cell deathmay
play a role in the observed deformations of neural tube inUBR1/
UBR2/ embryos. Indeed, significantly increased amounts of
TUNEL-positive cells were observed throughout the neural tubes
of ED10.5 UBR1/UBR2/ embryos (more prominently in the
forebrain) (Fig. 3 J and K). We conclude that the thinner and
morphologically distorted neuroepithelial layers in UBR1/
UBR2/ embryos (Fig. 2A–F) resulted fromboth a decrease in cell
proliferation and increase in apoptosis.
The neuroepithelium of normal ED10.5 embryos consists of
the VZ layer, containing proliferating neural precursors, and the
mantle, containing postmitotic neurons (27, 28). In contrast, the
neuroepithelium of ED10.5 UBR1/UBR2/ embryos could be
subdivided into three layers, BrdUpH3 cells, BrdUpH3 cells,
and BrdUpH3 cells (Fig. 3F). When progenitor cells in the
wild-type VZ become postmitotic, they usually migrate to the
mantle. However, at later stages of neurogenesis, some precursor
cells that leave the VZ remain mitotically active and enter a
secondary proliferative zone called the subventricular zone (SVZ),
between the VZ and the mantle (27–29). The nuclei of cells in the
VZ migrate up and down (within cells containing them) along
the apical–basal axis during the cell cycle, a movement called the
interkinetic nuclear migration, whereas the nuclei of cells in the
SVZ do not exhibit this effect. A parsimonious interpretation of
the three layers observed with UBR1/ UBR2/ embryos, vis-a-
vis two layers in control embryos (Fig. 3E and F), is that the former
are the VZ (BrdUpH3), SVZ (BrdUpH3), and mantle
(BrdUpH3) layers. The SVZ (BrdUpH3) layer in UBR1/
Fig. 2. Abnormal development of the central nervous system in UBR1/UBR2/ embryos. (A and B) Transverse sections of ED10.5 UBR1/UBR2/ (B) and
littermate UBR1/UBR2/ control (A) embryos stained for neurofilaments. (C–F) Hematoxylineosin-stained transverse sections of UBR1/UBR2/ embryos
(D and F) and littermate control embryos (wild type in C; UBR1/UBR2/ in E) at ED10.5 (C and D) and ED11.5 (E and F). (G and H) Dorsal views of ED11.5
UBR1/UBR2/ (H) and control (UBR1/UBR2/) (G) embryos. drg, dorsal root ganglion; mt, motor neuron; nt, neural tube; SC, spinal cord; FB, forebrain; HB,
hindbrain. Asterisk and arrowheads in H mark the swollen pericardial sac and kinked neural tube, respectively. (Scale bars: 200 m.)
Fig. 3. Abnormal proliferation patterns
of UBR1/UBR2/ neural precursors.
Transverse sections of ED10.5 UBR1/
UBR2/ embryos (B, D, F, H, Ic, Id, K, and
M) and littermate control embryos
(UBR1/UBR2/ in A, C, E, G, Ia, Ib, and
L;UBR1/UBR2/ in J) that were stained
for BrdU (red), pH3 (green), nestin (red),
TUNEL (green), andor Ki67 (red), as indi-
cated above. (E and F) Enlarged views of
boxed hindbrain regions in C and D. (I)
Representative morphologies of pH3-
positive nuclei of cells in ED10.5 UBR1/
UBR2/ (c and d) and control (a and b)
hindbrains. (Scale bars: A–D, L, and M, 200
m; E and F, 40 m;G,H, J, and K, 100 m.)
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UBR2/ embryos may be the result of premature migration of
mitotically active neural precursors from the VZ. To address this
possibility in particular, we used antibodies to nestin (a marker for
neural precursors in the VZ), to microtubule-associated protein 2
(a marker for dendrites of postmeiotic neurons in the mantle), and
to tubulin-III (a marker for tubulin-rich processes of postmitotic
neurons in themantle). In agreement with the above interpretation,
the BrdUpH3 SVZ-like zone inUBR1/UBR2/ embryos was
located between the layer containing nestin-positive cells (Fig. 4F)
and the mantle layer containing postmitotic neurons (Fig. 4 H and
J). GABA is produced in specific neurons of the forebrain that are
derived from the SVZ (30). We asked, by staining for GABA,
whether GABA-producing neurons would be precociously gener-
ated in the forebrains of ED10.5 UBR1/UBR2/ embryos. That
was indeed the case (Fig. 4L): yet another result consistent with the
above interpretation.
Neural progenitor cells in the neural tube normally enter the S
phase when their nuclei are located proximally to the outer half of
VZ. The subsequent interkinetic nuclear migration brings the
nuclei closer to the ventricular surface, followed by mitosis (27, 28).
The patterns observed with neural tube cells in UBR1/UBR2/
embryos were different, given the near absence of S-phase cells
and the almost completely suppressed cell proliferation in the VZ,
normally the main proliferative zone. But cell proliferation was
allowed in the SVZ (normally the secondary proliferative zone) of
double-mutant embryos (see above). Our findings (Figs. 2–4)
suggest that neural progenitor cells in UBR1/UBR2/ embryos
prematurely migrate from the VZ to the SVZ, possibly as a result
of their premature differentiation. If a reduced proliferation of
neural precursors is accompanied by their accelerated differentia-
tion, neural precursors would be gradually depleted as neurogenesis
progresses. A relative depletion of cells positive for nestin (amarker
for neural precursors in the VZ) was indeed observed in ED10.5
UBR1/UBR2/ embryos (Figs. 3K and 4F), and this depletion
became more severe by ED11.5 (data not shown). Taken together,
our results indicate that theUb ligasesUBR1 andUBR2 are critical
for the proper regulation of proliferation and differentiation of
neural precursor cells during embryogenesis.
Impaired Cardiovascular Development in Embryos Lacking UBR1 and
UBR2. In contrast to single mutants (21, 24), the double-mutant
UBR1/UBR2/ embryos had severe cardiovascular defects. The
hearts of ED9.5 UBR1/UBR2/ embryos were apparently nor-
mal (data not shown), but by ED10.5, the double mutants devel-
oped local hemorrhages, a swollen pericardial sac, andor a peri-
cardial effusion (Figs. 1 F and G, 2H, and 5B), indicating the
leakage of blood into the abdominal cavity as well as other defects.
Amongst them was a large space between the heart and pericar-
dium in ED10.5 UBR1/UBR2/ embryos, consistent with the
accumulation of pericardial fluid (Fig. 5D, asterisk). Development
of the atria and ventricles was largely arrested in double mutants by
ED10.5. Disorganization of the myocardial wall was also observed,
with variable levels of ventricular atrophy (Fig. 5D, arrowhead).
Fig. 4. Abnormal differentiation patterns of
UBR1/UBR2/ neural precursors. Transverse sec-
tions of forebrain regions (boxed in A and B) in
ED10.5 UBR1/UBR2/ (B, D, F, H, J, and L) and
UBR1/UBR2/ control (A,C, E,G, I, andK) embryos
were stained for DNA (blue), BrdU (red), pH3
(green), nestin (red), microtubule-associated pro-
tein 2 (MAP2) (green), tubulin-III (red), andor
GABA (green), as indicated above. (Scale bars: A and
B, 200 m; C–L, 40 m.)
Fig. 5. Impaired cardiovascular development in UBR1/UBR2/ embryos.
(A and B) Lateral views of ED10.5UBR1/UBR2/ (B) and littermateUBR1/
UBR2/ control (A) embryos. Markings are as follows: arrow, abnormal heart
morphology; asterisk, swollen pericardial sac; arrowhead, hemorrhage. (Cand
D) Hematoxylineosin-stained transverse sections of ED10.5 UBR1/UBR2/
(D) and littermate wild-type control (C) hearts. Markings are as follows:
asterisk, swollen pericardial space; arrowheads, ventricular wall; arrows, sites
of septum formation in wild-type (but not in UBR1/UBR2/) embryos. RA,
right atrium; LA, left atrium; RV; right ventricle; LV, left ventricle. (E and F)
PECAM-stained ED10.5UBR1/UBR2/ (F) andUBR1/UBR2/ (E) yolk sacs.
Arrowheads in F indicate some of the differences in the branching patterns
relative to wild-type embryos. (G and H) PECAM-stained ED10.5 UBR1/
UBR2/ (H) and UBR1/UBR2/ (G) whole embryos. Arrowheads mark the
intracranial artery. (Scale bars: 100 m.)














Although control hearts at this stage had abundant and thick
trabeculae, the trabeculations in UBR1/UBR2/ embryos were
thinner and less abundant. Interatrial and interventricular septa
began to form in the hearts of control embryos by ED10.5 (Fig. 5C,
arrow) but were not observed in double mutants. In the control
hearts, the staining for tropomyosin (present in cardiomyocytes)
was, as expected, cytoplasmic, delineating well organized cardio-
myocyte-based cardiac structures (data not shown). In contrast, the
tropomyosin staining in the UBR1/UBR2/ hearts was both
cytoplasmic and nuclear, in addition to revealing a morphological
disorganization (data not shown). Taken together, these results
indicate that proliferation of UBR1/UBR2/ cardiac cells was
impaired at ED10.5, resulting in multiple defects.
Staining for platelet endothelial cell adhesion molecule (PE-
CAM) 1, a marker for blood vessels, showed that the honeycomb-
like network of primary vascular plexus formed normally in the
ED9.5 UBR1/UBR2/ yolk sacs and embryos proper (data not
shown). In addition, UBR1/UBR2/ yolk sacs had apparently
normal endothelial cells as well as blood islands that contained
nucleated fetal erythrocytes. However, by ED10.5, the UBR1/
UBR2/ yolk sacs appeared pale, and their blood vessels were
thinner and less branched than their wild-type counterparts. Stain-
ing for PECAM-1 showed that the growth, remodeling, and branch-
ing of both small and large vessels were impaired in double-mutant
embryos (Fig. 5F, arrowhead). Similarly, larger vessels such as the
intracranial artery (Fig. 5H, arrowhead) were thin and poorly
developed in ED10.5 UBR1/UBR2/ embryos. These findings
and related results (Fig. 5 anddata shown) indicated thatUBR1and
UBR2 were required for normal cardiovascular development.
Molecular Analysis of Mouse Embryos Lacking UBR1 and UBR2. We
focused, in the present study, on molecular circuits known to
underlie cell proliferation, neurogenesis, and cardiovascular devel-
opment. The observed suppression of cell proliferation in both the
nervous and cardiovascular systems of UBR1/UBR2/ embryos
suggested that this suppression may also take place in other tissues
of double-mutant embryos. Therefore, we used whole-embryo
extracts to examine the levels of cyclins, specific subunits of
cyclin-dependent kinases that control cell growth and division (31).
Immunoblotting with antibodies to cyclinsD1,D2, andD3 revealed
their decreased levels in ED10.5 UBR1/UBR2/ embryos, with
the level of cyclin D3 being particularly low (Fig. 6B). The levels of
other tested cyclins, A, B, and E, were unaffected by the absence of
UBR1 andUBR2 (Fig. 6B). Semiquantitative RT-PCR and North-
ern hybridization showed that the levels of Ccnd3 mRNA were
indistinguishable between ED10.5UBR1/UBR2/ embryos and
controls (data not shown). Thus, the strong decrease of cyclin D3
in double-mutant embryos (Fig. 6B) could not be caused by effects
on transcription or mRNA stability, suggesting either a shorter
half-life of this regulator andor a less efficient translation of its
mRNA. Because D-type cyclins are critical for the conversion of
prereplication complex into an active replication fork at the G1–S
transition (31), our findingswith cyclinD3 (Fig. 6B)may be relevant
to the observed decrease in the levels of S-phase neural precursor
cells in UBR1/UBR2/ embryos (Fig. 3).
The defects of UBR1/UBR2/ embryos, a deformed neural
tube and the impairment of neurogenesis and cardiovascular de-
velopment, are also a major feature of mouse embryos lacking
components of the Notch signaling pathway. The functions of this
pathway include the inhibition of neuronal differentiation, a pattern
of control that maintains the required cell-type diversity of neural
precursors (32–34). A ligand-activated Notch1 is cleaved by the
-secretase complex, and the released intracellular domain of
Notch1 translocates to the nucleus, where it forms a complex with
RBP-J (recombination signal sequence-binding protein J) and
thereby activates target genes of the Notch pathway (32–34).
ED10.5 UBR1/UBR2/ embryos contained a significantly de-
creased level of Notch1 in comparison with littermate controls (Fig.
6A), whereas the level of Notch1 mRNA was not significantly
affected (data not shown). Thus, a suppression of the Notch
pathway in UBR1/UBR2/ embryos may account, in part, for
the impaired neurogenesis and cardiovascular development in this
mutant background.
We also asked whether the absence of both UBR1 and UBR2
would affect the mitogen-activated protein kinase (MAPK) path-
way, which regulates, in particular, cell proliferation, differentia-
tion, and apoptosis. The level of phosphorylated (active) p38
MAPK was substantially increased in ED10.5 UBR1/UBR2/
embryos in comparison with wild-type or single-mutant embryos
(Fig. 6C and data not shown), in contrast to the levels of phos-
phorylated or unphosphorylated extracellular signal-regulated ki-
nase and c-Jun N-terminal kinase MAPKs (data not shown).
Activated p38 MAPK causes the exit from the cell cycle and
differentiation in many cell types (35). Taken together, our bio-
chemical findings (Fig. 6) suggest that decreased levels of D-type
cyclins and Notch1, as well as the enhanced phosphorylation of p38
MAPK, are amongst the causes of multiple phenotypic defects
(Figs. 1–5) of UBR1/UBR2/ embryos. Because both D3 and
Notch1 decrease in concentration in UBR1/UBR2/ embryos
(Fig. 6), UBR1 and UBR2 apparently down-regulate specific
(currently unknown) proteins that are a part of circuits that
influence the levels of Notch1 andor D3.
Concluding Remarks. Themultiple and severe defects of the double-
mutant UBR1/UBR2/ mice, including their embryonic lethal-
ity (Figs. 1–5), are in contrast to the viability of UBR1/mice and
the conditional (genetic background-dependent) viability of
UBR2/mice (21, 24). Given both strong sequelogy similarity (25)
between UBR1 and UBR2 and their previously demonstrated
indistinguishable patterns of binding to destabilizing N-terminal
residues (21), our results can be formally accounted for by presum-
ing that the substrate recognition and other properties of UBR1
Fig. 6. Immunoblot analysis of UBR1/UBR2/ embryos. Whole-embryo
extracts from ED10.5 UBR1/UBR2/ and littermate control embryos were
immunoblotted for the proteins indicated in A–C.
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andUBR2 are identical or nearly so. In this interpretation, themain
reason for greater severity of the double-mutant phenotype would
be significant differences in the expression patterns of UBR1 and
UBR2 in specific cell types and tissues. Some of these differences
were detected previously (21). According to this model, the previ-
ously observed apoptosis of meiotic spermatocytes in UBR2/
mice (21) is caused by functionally insufficient levels of UBR1 in
these cells, which, in wild-type mice, would be ‘‘rescued’’ by UBR2.
In a converse example, the same model would predict that defects
(and eventual apoptosis) of the acinar pancreatic cells in UBR1/
human patients with Johanson–Blizzard syndrome (26) are caused
by insufficient levels of UBR2 in these cells, which are normally
‘‘rescued’’ by UBR1.
Although no evidence at present directly contradicts this inter-
pretation, the actual disposition is likely to be more complex. For
example, S. cerevisiae UBR1, the sole E3 Ub ligase of the yeast
N-end rule pathway, contains at least three substrate-binding sites,
one of which recognizes the transcriptional repressor CUP9
through its internal (non-N-terminal) degron (see the Introduction)
(16, 17). Because S. cerevisiaeUBR1 and mouse UBR1 and UBR2
are sequelogous (25) throughout their lengths (4, 23), and because
mouse UBR1 and UBR2 do contain the first two substrate-binding
sites (21, 24), one would expect either of them to contain a third
substrate-binding site aswell. In contrast toS. cerevisiaeUBR1, such
third sites in mammalian UBR1 and UBR2 are still conjectural.
[Although human UBR1 and UBR2 bind to RECQL4, a putative
helicase that is absent or damaged in patients with the Rothmund–
Thomson syndrome (36), it is unclear whether this binding is
relevant to the targeting that results in substrates’ ubiquitylation and
degradation.]
If UBR1 and UBR2 contain the third substrate-binding sites,
such sites may be similar in their recognition specificity, in which
case the above ‘‘differential expression’’ model might suffice to
account for the entire gamut of phenotypic differences between
UBR1/UBR2/ mice and their single-mutant counterparts.
However, if the (presumed) third substrate-binding sites of UBR1
and UBR2 are significantly divergent in regard to substrates they
recognize, the relative severity of double-mutant phenotype may
also stem from this divergence. The mammalian N-end rule path-
way contains at least four, and possibly as many as seven, distinct
N-recognins, including UBR1 and UBR2 (4). Although all of these
E3 Ub ligases share the UBR-box domain, they are largely dissim-
ilar otherwise, with the exception of UBR1 and UBR2 (4). The
remarkable range ofUb ligases thatmediate themammalianN-end
rule pathway is yet another complexity that the eventual mecha-
nistic (circuits-based) understanding of defects in UBR1/
UBR2/ mice (Figs. 1–5) would have to illuminate.
Materials and Methods
UBR1/UBR2/ Mice. The construction and characterization of
single-mutantUBR1/ andUBR2/mice are described in refs. 21
and 24.UBR1/UBR2/mice were produced through compound
heterozygous crosses in the mixed 129SvImJC57BL6 genetic
background (4).
Histology, Immunohistochemistry, and Antibodies. Embryos were
fixed in 4% paraformaldehyde before processing for paraffin
sectioning. Paraffin-embedded embryos were serially sectioned and
stained with hematoxylineosin or antibodies. Antibodies used for
immunohistochemistry or immunoblotting were to the following
antigens: neurofilaments, tropomyosin, and nestin (Developmental
Studies Hybridoma Bank, Iowa City, IA); cyclins A, B, D1, D2, D3,
and E (Santa Cruz Biotechnology); p38, phospho-p38, and Notch-
ICD (intracellular domain of Notch1) (Cell Signaling Technology,
Beverly, MA); Notch1, tubulin-III, GABA, and actin (Sigma-
Aldrich); MAP2 (microtubule-associated protein 2) (Chemicon);
BrdU (Accurate Chemicals); pH3 (Upstate Biotechnology, Lake
Placid, NY); and PECAM-1 (Pharmingen). Secondary antibodies
were conjugated toAlexa Fluor 555 (Molecular Probes), FITC, Cy3
(Jackson ImmunoResearch), or horseradish peroxidase (Santa
Cruz Biotechnology).
Measurements of Cell Proliferation and Apoptosis. For proliferation
assays, pregnant mice were injected i.p. with BrdU (Sigma) (50
gg of body weight) and killed 1–5 h later. Embryos were fixed,
processed for paraffin sectioning, and stained for BrdU. To visu-
alize apoptotic nuclei, transverse sections of embryos were pro-
cessed for the TUNEL assay by using the In Situ Cell Death
Detection Kit (Roche Applied Science, Indianapolis) and then
were counterstained with DAPI.
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